/ Target Industries / Healthcare & Life Sciences

Healthcare & Life Sciences

The Houston region is a flourishing locale for the life sciences, primarily due to the influence of the Texas Medical Center (TMC), which is the world’s largest medical complex.


Specializing in cardiovascular research and treatment (Debakey Institute) as well as oncology (M.D. Anderson), the Texas Medical Center (TMC) has garnered global recognition for its research contributions. Complementing this research base is a complex assortment of regional hospitals and treatment facilities capable of treating any condition. It is the combination of both research and treatment that make the TMC unique.

Pearland is located just minutes from the TMC and its 54 medical institutions, placing Pearland in a strategic position to attract research, treatment and health care support facilities. Pearland’s 77584 zip code is home to more TMC workers than any other zip code in the Houston region.

Benefits for life sciences and health care companies in the Pearland region include:

Access to Talent:  Currently over 13% of Pearland residents work in the health care sector.  With a median age of 34.7 and over 50 percent of the adult population holding a four-year degree or higher, Pearland employers have access to a young, diverse workforce.  And this growth shows no signs of slowing down.  Over the next five years, the fastest growing occupation group in Pearland is expected to be healthcare support occupations with a 3.5% year-over-year rate of growth.

Location:  Pearland’s location at the intersection of State Highway 288 and Beltway 8 has made the community a strategic choice for health care providers looking to serve our rapidly growing market.


In 2018, Lonza Houston, Inc. completed construction on a 300,000 square-foot manufacturing facility – the largest dedicated cell-and-gene-therapy manufacturing facility in the world.  The facility includes office space, process development, quality control laboratories and a fully segregated fill/finish suite.  The facility is home to 310 employees and plans to employ 400 by early 2020.  The project broke ground in April 2016 as a 100,000 square-foot biotech facility on an 11-acre site in the Lower Kirby District.  In September 2016, Lonza announced an expansion to facility currently under construction for development of viral gene and virally-modified cell therapeutics for customers worldwide.

In 2017, Adient Medical, a medical device manufacturer that develops implantable medical devices that dissolve for the prevention of pulmonary embolism, expanded its offices with a relocation to a 1,900 square-foot office and research space in Reflection Bay at Shadow Creek.  The company was founded in Pearland in 2012.

In 2014, Base Pair Biotechnologies, a developer of research and medical diagnostics made of DNA for research institutions, universities and pharmaceutical companies, relocated its offices to Pearland.  In October 2017, the company expanded with a relocation to a 5,000 square-foot office and laboratory space on Broadway, allowing for an additional eight employees.

In 2013, Kelsey Seybold relocated its administrative headquarters to Pearland. The 170,000 square-foot, four-story office building is located on an 18 acre site in Shadow Creek Ranch on the northeast corner of Kirby Drive and Shadow Creek Parkway, just west of State Highway 288.  The administrative offices are home to 1,000 employees who support Kelsey-Seybold’s 370 physicians providing primary care and specialty care at 20 clinic locations throughout the region.

In 2011, PEDC recruited Merit Medical Systems to Pearland.  The global medical device company opened a 92,000 SF research and development and manufacturing facility on a 12-acre site in Pearland’s Lower Kirby District in October 2014.  Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy. Merit serves client hospitals worldwide.

In 2010, Saint Paul, Minnesota-based cardiovascular medical device developer, Cardiovascular Systems, Inc. opened its state-of-the-art facility for the manufacturing of commercialized interventional treatment systems for vascular disease.


Hospital Corporation of America (HCA) opened HCA Houston Healthcare Pearland, a 30-bed, acute care hospital in Pearland in February 2015. HCA Healthcare Houston Pearland is located at the southwest intersection of Highway 288 and County Road 2234 (Shadow Creek Parkway) on a 48-acre site that is currently home to a full-service, freestanding 24-hour emergency department, imaging center and a 3-story, 80,000 square-foot medical office building.  HCA Houston Healthcare Pearland is a 144,000 square-foot, $71 million facility featuring surgical suites, medical/surgical beds, intensive care beds, an emergency department, and an imaging department that will include magnetic resonance imaging (MRI), computerized tomography (CT), catheterization lab, echocardiogram testing, and nuclear medicine modalities. The hospital’s women’s service provides digital mammography, labor and delivery suites, cesarean section operating rooms and a newborn nursery.

Memorial Hermann completed construction on a new medical campus in Pearland in 2016. The centerpiece of the new medical campus is a 4-story, 64-bed acute care hospital that features an intensive care unit, operating rooms, cardiac catheterization labs, medical/surgical units, women’s and neonatology services.  The multi-purpose complex is located on a 40-acre site that is also home to an outpatient imaging center, diagnostic lab services, and two medical office buildings.  The campus also includes a “one-of-a-kind” convenient care center, which opened in February 2014, that provides one-stop, highly coordinated access to adult and pediatric primary care, specialty physicians, sports medicine and rehabilitation, and a 24-hour emergency room.

Encompass Health opened a 40-bed rehabilitation hospital on Business Center Drive in 2017.